Eli Lilly (NYSE:LLY) climbed about 0.5% in premarket trading Tuesday as the company builds roughly $1.5 billion in inventory for its upcoming oral weight-loss pill, Orforglipron. The pill, expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results